AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimidale M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Allen Dale Biosciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimidale M 2mg/500mg Tablet SR

Diabetac Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetac Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, incorporating dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to effective diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods or juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are typically recommended.

Uses of Glimidale M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimidale M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimidale M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimidale M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimidale M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glimidale M 2mg/500mg sustained-release tablet should be taken with a meal.

How Glimidale M 2mg/500mg Tablet SR works:

Glimidale M 2mg/500mg Extended-Release Tablets combine glimepiride and metformin, two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Glimidale M 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Prolonged-release Glimidale M 2mg/500mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimidale M 2mg/500mg tablets are contraindicated for use while breastfeeding due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimidale M 2mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimidale M 2mg/500mg SR tablets. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimidale M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. For those with mild to moderate liver disease, initiate treatment with a low dose of Glimidale M 2mg/500mg SR tablets; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimidale M 2mg/500mg Tablet SR :

Should you forget a Glimidale M 2mg/500mg SR tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimidale M 2mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimidale M 2mg/500mg Tablet SR

Retain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medicine. Prevent access by children, pets, and other individuals.
Glimidale M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially dangerous adverse effect is particularly concerning for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms might encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Glimidale M 2mg/500mg Tablet SR and seek immediate medical attention.
Glimepiride and metformin, combined as Glimidale M 2mg/500mg sustained-release tablets, manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when coupled with a healthy diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin acts by decreasing hepatic glucose output and increasing insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glimidale M 2mg/500mg sustained-release tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal discomfort, loose stools, and cephalalgia. Rarely, but seriously, lactic acidosis may occur. Prolonged therapy is also linked to vitamin B12 deficiency.
Indeed, prolonged use of Glimidale M 2mg/500mg sustained-release tablets can lead to Vitamin B12 deficiency. This medication hinders the gastrointestinal absorption of Vitamin B12. Consequently, untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some experts at least annually.
Indeed, Glimidale M 2mg/500mg SR tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available simple carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimidale M 2mg/500mg SR tablets with alcohol is unsafe. Alcohol consumption can reduce blood glucose, potentially causing hypoglycemia, and raises the risk of lactic acidosis.
Glimidale M 2mg/500mg Tab...
70
MRP 85
17% off